Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-25-003951
Filing Date
2025-01-16
Accepted
2025-01-16 08:03:19
Documents
2
Period of Report
2025-01-15

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm252892-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm252892-1_3seq1.xml 3 2779
2 EXHIBIT 24 tm252892d1_ex24.htm EX-24 9267
  Complete submission text file 0001104659-25-003951.txt   13500
Mailing Address C/O OCERA THERAPEUTICS, INC. 525 UNIVERSITY AVENUE, SUITE 610 PALO ALTO CA 94301
Business Address
Patni Rajiv (Reporting) CIK: 0001616200 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38410 | Film No.: 25534340

Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Issuer) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)